According to Western blot analysis, MT1 expression was lower in PBMCs from MG patients than in those from HCs, whereas no difference in retinoic acid-related orphan receptor (ROR)α expression was observed between these groups (Figure 1B, 1C). This evidence concerns the gene RORA and myasthenia gravis.